CHIRP Program
MNCM Status Page
Registration & Portal Maintenance
Clinic and Provider Registration (Resources)
Clinic and Provider Registration (FAQs)
PIPE Medical Groups Resources
PIPE Medical Group Onboarding
PIPE Medical Group Guides & Specs
PIPE Medical Group Instructional Videos
PIPE Medical Group FAQ
PIPE Payer Resources
PIPE Payer Onboarding
PIPE Payer Guides & File Field Specifications
PIPE Payer FAQ
Technical, Submission & Validation Support
Technical Questions
Measure Questions
General Measure Question
HEDIS Questions
Orthopedic Measures
Oncology Measures
Statewide Results
Preliminary Clinical Quality Measure Results
Final Clinical Quality Measure Results
Security
Security Policies

Oncology Measures - Symptom Control During Chemotherapy

Creation date: 9/13/2021 11:20 AM Updated: 7/24/2023 8:34 AM cancer

MNCM will restart data collection for the oncology measures known as Symptom Control During Chemotherapy (SCDC) for Measurement Year/Dates of Service 2022 (reported in 2023).

Collection will begin 2023 Measurement Year (reported in 2024) for private reporting. Public reporting will begin the following year (2024 MY reported in 2025).

Data collection will be through MNCM’s Process Intelligence Performance Engine (PIPE) system; this will not be collected through MNCM's Direct Data Submission (DDS) process.

Please refer to the PIPE Data Field Specifications for instructions about data submission. Additional documents are attached below (e.g., measure background, measure calculation information).

SCDC Cancer Measures MARC 2-14-2018.pdf

Supplemental Guide_PIPE Symptom Control During Chemotherapy Measure Calculations v2 FINAL.pdf

Oncology Measures 2022 MY Implementation_20211026.docx

This category is for questions related to the oncology clinical quality measure suite.

Oncology Measures - Symptom Control During Chemotherapy

On this page